Men using the female estrogen hormone replacement therapy (HRT) patches as treatment for advanced prostate cancer suffer fewer side effects than with other treatments, according to a new study reported in the latest issue of the Journal of Urology (December 2004). Scientists at Hammersmith Hospitals NHS Trust and Imperial College London have already shown that HRT patches have considerable potential as prostate cancer therapy. For the first time they have additionally shown that this therapy, unlike other current treatments, prevents bone loss (osteoporosis) and instead causes an increase in bone density. These early studies confirm the considerable promise of estrogen hormone patches in advanced prostate cancer.
Prostate cancer is the most common male cancer in the UK, with about 20,000 cases diagnosed every year. Affecting men generally over the age of 45, prostate cancer grows slowly and may go undetected for many years. In some cases, the cancer can spread to bones and other organs of the body. The causes of prostate cancer are mainly unknown, but it requires the male hormone testosterone, produced in the testicles, to develop and grow. Treatment of advanced disease has resulted in therapies that reduce or remove testosterone from the body, via surgical or medical ‘castration.’
“Depriving the cancer of testosterone is the well accepted method of slowing down the progression of advanced prostate cancer,” comments lead author Mr Paul Abel, consultant urologist at Hammersmith Hospitals NHS Trust and Imperial College London. “The problem is that conventional current therapies which involve testosterone reduction can have serious side effects such as osteoporosis, which has not been fully appreciated until quite recently. This has led to reports of an increasing chance of bone fractures in these patients. Our study shows that oestrogen therapy delivered by skin patches not only controls prostate cancer, but prevents bone loss and in most cases, increases bone mass.”
Simon Wilde | alfa
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
23.04.2018 | Physics and Astronomy
23.04.2018 | Physics and Astronomy
23.04.2018 | Trade Fair News